​​Solid tumor cancer and lung cancer​​ research hub

MK-1084 Single and Multiple Dose Healthy Participant Study

This early-stage study is testing a new medicine called MK-1084 in healthy volunteers. It aims to see how safe the drug is and how the body handles it at different doses. This information will help researchers understand if it could be a future treatment for cancers like solid tumours and lung cancer.